Researchers at McMaster University have discovered a new antibiotic that kills some of the world's most dangerous and ...

Reflecting continuing concerns over medicine quality and regulatory compliance in India's pharmaceutical market, the Central ...

The audio version of this article is generated by AI-based technology. Mispronunciations can occur. We are working with our partners to continually review and improve the results. Some Canadian ...

Add Yahoo as a preferred source to see more of our stories on Google. Brian Rodrigues is a professor in the University of British Columbia's pharmaceutical sciences faculty. (Submitted by Brian ...

Trump said he is increasing the number of products on the platform by nearly seven times, adding more than 600 generic drugs ...

India got it earlier this year, and Canada approved it last month. But when is the United States going to get a generic version of Ozempic? Subscribe to read this story ad-free Get unlimited access to ...

The National Drug Control Strategy is prepared biennially by the Office of National Drug Control Policy. This document provides a strategic roadmap for the Administration to continue dismantling the ...

Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation and legislation. He is also the author of the morning Pharmalittle newsletter ...

Drug names are complicated things. For one, they must linguistically fulfill the role of being a shiny bauble for prescribers to be memorable enough to outshine competitors. But they must also walk a ...

Two of Walmart's house brands, Equate and Great Value, are known for their low prices, and have their fans, who compare the products to more recognizable brand names for both savings and quality.

President Donald Trump ordered a 100% tariff on brand-name pharmaceuticals produced overseas as his administration escalates efforts to push drug companies to manufacture in the United States. Trump ...

President Trump signed an executive order Thursday targeting imported brand name drugs with a 100 percent tariff, citing the U.S.’s “import reliance” as reason for the decision. “I have determined ...